Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer.

Maczis, Melissa A

Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer. [electronic resource] - Journal of lipid research 12 2018 - 2297-2307 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

1539-7262

10.1194/jlr.M085191 doi


Animals
Blotting, Western
Breast Neoplasms--genetics
Cell Line, Tumor
Cell Proliferation--drug effects
Drug Resistance, Neoplasm--genetics
Gene Expression Regulation, Neoplastic--drug effects
Humans
Mice
Microscopy, Confocal
Phosphotransferases (Alcohol Group Acceptor)--genetics
Receptors, Estrogen--genetics
Signal Transduction--drug effects
Tamoxifen--pharmacology
Tandem Mass Spectrometry